Home  /  Resource Library  /  Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease

Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease

Results of a study investigating BIRC3 inactivation as a possible prognostic biomarker for chronic lymphocytic leukemia.